Haroutyun Joulfayan
Overview
Explore the profile of Haroutyun Joulfayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makunts T, Joulfayan H, Abagyan R
JMIRx Med
. 2024 May;
5:e58273.
PMID: 38738852
No abstract available.
2.
Makunts T, Joulfayan H, Abagyan R
JMIRx Med
. 2024 May;
5:e55976.
PMID: 38738836
Background: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are one of the most commonly used drugs for type 2 diabetes mellitus. Clinical guidelines recommend GLP-1 RAs as an adjunct to diabetes...
3.
Makunts T, Joulfayan H, Abagyan R
medRxiv
. 2023 Dec;
PMID: 38045343
Glucagon receptor-like peptide receptor agonists, GLP-1 RAs, are one of the most commonly used drugs for type-2 diabetes mellitus. The clinical guidelines recommend GLP-1 RAs as adjunct to diabetes therapy...
4.
Joulfayan H, Makunts T, Abagyan R
Sci Rep
. 2023 Jun;
13(1):10448.
PMID: 37369753
Rheumatoid arthritis, RA, is a chronic autoimmune disease characterized by joint pain, tenderness, swelling, and stiffness. This disease affects nearly 1% of the world population. RA predominates in females and...